<?xml version="1.0" encoding="UTF-8"?>
<p>The spectrum of clinical manifestations of 2019‐nCoV infection includes fever, myalgia, cough and dyspnea, and less frequently headache, diarrhea, nausea and vomiting.
 <xref rid="jth14781-bib-0004" ref-type="ref">
  <sup>4</sup>
 </xref> The prevalence of an asymptomatic form of this disease is yet to be determined. In those patients demonstrating clinical symptoms, progression to pneumonia appears frequent, with imaging evidence of parenchymal disease, acute respiratory distress occurring in 30% of patients, 30% requiring intensive care unit admission, and 10% to 15% of patients dying from their disease.
 <xref rid="jth14781-bib-0004" ref-type="ref">
  <sup>4</sup>
 </xref> High plasma levels of proinflammatory cytokines (interleukin‐2, interleukin‐7, granulocyte colony‐stimulating factor, IP10, MCP1, MIP1A. and tumor necrosis factor‐α) have been observed in 2019‐nCoV patients admitted to intensive care units, suggesting that a cytokine storm effect may be developing in these individuals with severe disease.
 <xref rid="jth14781-bib-0004" ref-type="ref">
  <sup>4</sup>
 </xref>
</p>
